Show simple item record

dc.contributor.authorManchanda, Ren_US
dc.contributor.authorMenon, Uen_US
dc.date.accessioned2016-02-19T11:38:53Z
dc.date.available2016-01-01en_US
dc.date.issued2016-02en_US
dc.date.submitted2016-02-02T09:47:59.189Z
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/11153
dc.format.extent463 - ?en_US
dc.languageengen_US
dc.relation.ispartofBJOGen_US
dc.rightsThis is the peer reviewed version of the following article: Manchanda, R. and Menon, U. (2016), Opportunistic bilateral salpingectomy (OBS) for the prevention of ovarian cancer should be offered in the context of a clinical trial. BJOG: An International Journal of Obstetrics & Gynaecology, 123: 463. doi: 10.1111/1471-0528.13741, which has been published in final form at http://dx.doi.org/10.1111/1471-0528.13741. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
dc.subjectClinical Trials as Topicen_US
dc.subjectFemaleen_US
dc.subjectHumansen_US
dc.subjectOvarian Neoplasmsen_US
dc.subjectProphylactic Surgical Proceduresen_US
dc.subjectSalpingectomyen_US
dc.titleOpportunistic bilateral salpingectomy (OBS) for the prevention of ovarian cancer should be offered in the context of a clinical trial: FOR: There is lack of clarity on a number of key issues.en_US
dc.typeArticle
dc.rights.holder© 2016 Royal College of Obstetricians and Gynaecologists.
dc.identifier.doi10.1111/1471-0528.13741en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/26810679en_US
pubs.issue3en_US
pubs.notes12 monthsen_US
pubs.publication-statusPublisheden_US
pubs.volume123en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record